Loading...
•
Mar 31, 2023
Teladoc Q1 2023 Earnings Report
Teladoc Health reported strong first-quarter results with revenue growth and progress in key operating metrics.
Key Takeaways
Teladoc Health's first quarter 2023 showed an 11% increase in revenue year-over-year, reaching $629.2 million. The company's net loss was $69.2 million, or $0.42 per share. The company saw growth in both U.S. and International revenues, as well as in the Integrated Care and BetterHelp segments.
Revenue increased by 11% year-over-year to $629.2 million.
Net loss was $69.2 million, or $0.42 per share.
U.S. revenues grew by 10% to $541.7 million, and International revenues grew by 18% to $87.6 million.
The BetterHelp segment revenue increased by 21% to $279.3 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For the second quarter of 2023, Teladoc Health expects revenue between $635 and $660 million and adjusted EBITDA between $60 and $68 million. Net loss per share is expected to be between ($0.55) and ($0.45), with U.S. Integrated Care Members between 84.5 and 85.5 million. For the full year 2023, revenue is projected to be between $2,575 and $2,675 million, and adjusted EBITDA between $285 and $325 million. Net loss per share for the year is expected to be between ($1.70) and ($1.25), with U.S. Integrated Care Members between 84 and 86 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...